These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3011271)

  • 1. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.
    Leder A; Pattengale PK; Kuo A; Stewart TA; Leder P
    Cell; 1986 May; 45(4):485-95. PubMed ID: 3011271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
    D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
    Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice.
    Iwamoto T; Takahashi M; Ito M; Hamaguchi M; Isobe K; Misawa N; Asai J; Yoshida T; Nakashima I
    Oncogene; 1990 Apr; 5(4):535-42. PubMed ID: 1691479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.
    Stöcklin E; Botteri F; Groner B
    J Cell Biol; 1993 Jul; 122(1):199-208. PubMed ID: 8100231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX; Papkoff J; Sarkar NH
    Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.
    Stewart TA; Pattengale PK; Leder P
    Cell; 1984 Oct; 38(3):627-37. PubMed ID: 6488314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
    Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
    Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
    Pääkkö P; Nuorva K; Kamel D; Soini Y
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
    Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C
    Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
    O'Banion MK; Levenson RM; Brinckmann UG; Young DA
    Mol Endocrinol; 1992 Sep; 6(9):1371-80. PubMed ID: 1331773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
    Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).
    Suda Y; Aizawa S; Furuta Y; Yagi T; Ikawa Y; Saitoh K; Yamada Y; Toyoshima K; Yamamoto T
    EMBO J; 1990 Jan; 9(1):181-90. PubMed ID: 2153076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
    Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
    Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
    Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
    Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.